Recent News

• 05.27.2025 - Stifel 2025 Virtual Ophthalmology Forum
• 05.21.2025 - Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
• 05.21.2025 - Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
• 05.14.2025 - Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
• 05.14.2025 - Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
• 05.09.2025 - Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
• 05.09.2025 - Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
• 05.08.2025 - Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
• 05.08.2025 - Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
• 05.07.2025 - Citizens Life Sciences Conference

Recent Filings

• 05.15.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 04.18.2025 - DEF 14A Other definitive proxy statements
• 04.18.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.18.2025 - ARS Annual Report to Security Holders
• 04.08.2025 - PRE 14A Other preliminary proxy statements